Novel drugs that target the metabolic reprogramming in renal cell cancer

por van der Mijn, Johannes C., Panka, David J., Geissler, Andrew K., Verheul, Henk. M., Mier, James W.
Publicado 2016

Irinotecan-Induced Dysarthria

por Dressel, Albertine J., van der Mijn, Johannes C., Aalders, IJke J., Rinkel, Rico N.P.M., van der Vliet, Hans J.
Publicado 2012

Lactic Acidosis in Prostate Cancer: Consider the Warburg Effect

por van der Mijn, Johannes C., Kuiper, Mathijs J., Siegert, Carl E.H., Wassenaar, Annabeth E., van Noesel, Carel J.M., Ogilvie, Aernout C.
Publicado 2017

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer

por Labots, Mariette, Gotink, Kristy J, Dekker, Henk, Azijli, Kaamar, van der Mijn, Johannes C, Huijts, Charlotte M, Piersma, Sander R, Jiménez, Connie R, Verheul, Henk M W
Publicado 2016

Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma

por van der Mijn, Johannes C., Fu, Leiping, Khani, Francesca, Zhang, Tuo, Molina, Ana M., Barbieri, Christopher E., Chen, Qiuying, Gross, Steven S., Gudas, Lorraine J., Nanus, David M.
Publicado 2019

Novel genetically engineered mouse models for clear cell renal cell carcinoma

por van der Mijn, Johannes C., Laursen, Kristian B., Fu, Leiping, Khani, Francesca, Dow, Lukas E., Nowak, Dawid G., Chen, Qiuying, Gross, Steven S., Nanus, David M., Gudas, Lorraine J.
Publicado 2023

NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma

por Kubala, Jaclyn M., Laursen, Kristian B., Schreiner, Ryan, Williams, Ryan M., van der Mijn, Johannes C., Crowley, Michael J., Mongan, Nigel P., Nanus, David M., Heller, Daniel A., Gudas, Lorraine J.
Publicado 2023

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study

por Labots, Mariette, Van der Mijn, Johannes C., Dekker, Henk, Ruijter, Rita, Pham, Thang V., Van der Vliet, Hans J., Van der Hoeven, Jacobus J.M., Meijer, Gerrit A., Verheul, Henk M.W.
Publicado 2018

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma

por van Linde, Myra E., van der Mijn, Johannes C., Pham, Thang V., Knol, Jaco C., Wedekind, Laurine E., Hovinga, Koos E., Aliaga, Esther Sanchez, Buter, Jan, Jimenez, Connie R., Reijneveld, Jaap C., Verheul, Henk M. W.
Publicado 2016

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer

por van der Mijn, Johannes C., Sol, Nik, Mellema, Wouter, Jimenez, Connie R., Piersma, Sander R., Dekker, Henk, Schutte, Lisette M., Smit, Egbert F., Broxterman, Henk J., Skog, Johan, Tannous, Bakhos A., Wurdinger, Thomas, Verheul, Henk M. W.
Publicado 2014

Rscreenorm: normalization of CRISPR and siRNA screen data for more reproducible hit selection

por Bachas, Costa, Hodzic, Jasmina, van der Mijn, Johannes C., Stoepker, Chantal, Verheul, Henk M. W., Wolthuis, Rob M. F., Felley-Bosco, Emanuela, van Wieringen, Wessel N., van Beusechem, Victor W., Brakenhoff, Ruud H., de Menezes, Renée X.
Publicado 2018

Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evi...

por Fransen van de Putte, Elisabeth E., van den Brink, Luna, Mansour, Mohamed A., van der Mijn, Johannes C., Wilgenhof, Sofie, van Thienen, Johannes V., Haanen, John B.A.G., Boleti, Ekaterini, Powles, Thomas, Zondervan, Patricia J., Graafland, Niels M., Bex, Axel
Publicado 2023

Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series

por van der Mijn, Johannes C., Al Hussein Al Awamlh, Bashir, Islam Khan, Aleem, Posada-Calderon, Lina, Oromendia, Clara, Fainberg, Jonathan, Alshak, Mark, Elahjji, Rahmi, Pierce, Hudson, Taylor, Benjamin, Gudas, Lorraine J., Nanus, David M., Molina, Ana M., Del Pizzo, Joseph, Scherr, Douglas S.
Publicado 2019

The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy

por van der Mijn, Johannes C., Eng, Kenneth W., Chandra, Pooja, Fernandez, Evan, Ramazanoglu, Sinan, Sigaras, Alexandros, Oromendia, Clara, Gudas, Lorraine J., Tagawa, Scott T., Nanus, David M., Faltas, Bishoy F., Beltran, Himisha, Sternberg, Cora N., Elemento, Olivier, Sboner, Andrea, Mosquera, Juan Miguel, Molina, Ana M.
Publicado 2022

Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome

por Labots, Mariette, Pham, Thang V., Honeywell, Richard J., Knol, Jaco C., Beekhof, Robin, de Goeij-de Haas, Richard, Dekker, Henk, Neerincx, Maarten, Piersma, Sander R., van der Mijn, Johannes C., van der Peet, Donald L., Meijerink, Martijn R., Peters, Godefridus J., van Grieken, Nicole C.T., Jiménez, Connie R., Verheul, Henk M.W.
Publicado 2020